%0 Journal Article
%B American Heart Journal
%D 2013
%G eng
%P 429-34. 
%T Evaluation of the dual peroxisome proliferator-activated receptor α/γ agonist aleglitazar to reduce cardiovascular events in patients with acute coronary syndrome and type 2 diabetes mellitus: rationale and design of the AleCardio trial.
%V 166
%2 PMID 24016490
%7 Epub 2013 Jul 26